Catheter Precision Valuation
| VTAK Stock | 0.42 0.01 2.33% |
Catheter Precision is undervalued. Catheter Precision shows a prevailing Real Value of USD2.06 per share. The current price of the firm is USD0.42. Our model approximates the value of Catheter Precision from analyzing the firm fundamentals such as Shares Outstanding of 8 M, operating margin of (29.22) %, and Return On Equity of -0.5 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Catheter Precision's valuation include:
Price Book 0.2659 | Enterprise Value 4 M | Enterprise Value Ebitda 0.0919 | Price Sales 7.821 | Trailing PE 0.0154 |
Undervalued
Today
Please note that Catheter Precision's price fluctuation is abnormally volatile at this time. Calculation of the real value of Catheter Precision is based on 3 months time horizon. Increasing Catheter Precision's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Catheter Precision's intrinsic value may or may not be the same as its current market price of 0.42, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.42 | Real 2.06 | Target 7.0 | Hype 0.44 | Naive 0.4 |
The intrinsic value of Catheter Precision's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Catheter Precision's stock price.
Estimating the potential upside or downside of Catheter Precision helps investors to forecast how Catheter stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Catheter Precision more accurately as focusing exclusively on Catheter Precision's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Catheter Precision's intrinsic value based on its ongoing forecasts of Catheter Precision's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Catheter Precision's closest peers.
Catheter Precision Cash |
|
Catheter Valuation Trend
Knowing Catheter Precision's actual value is paramount for traders when making sound investment determinations. Using both Catheter Precision's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Catheter Precision Total Value Analysis
Catheter Precision is at this time forecasted to have valuation of 4.03 M with market capitalization of 3.76 M, debt of 372 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Catheter Precision fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.03 M | 3.76 M | 372 K |
Catheter Precision Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Catheter Precision has an asset utilization ratio of 1.44 percent. This suggests that the Company is making USD0.0144 for each dollar of assets. An increasing asset utilization means that Catheter Precision is more efficient with each dollar of assets it utilizes for everyday operations.Catheter Precision Ownership Allocation
Catheter Precision shows 13.52 percent of its outstanding shares held by insiders and 4.66 percent owned by other corporate entities.Catheter Precision Profitability Analysis
The company reported the previous year's revenue of 442 K. Net Loss for the year was (70.57 M) with profit before overhead, payroll, taxes, and interest of 0.About Catheter Precision Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Catheter Precision. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Catheter Precision based exclusively on its fundamental and basic technical indicators. By analyzing Catheter Precision's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Catheter Precision's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Catheter Precision. We calculate exposure to Catheter Precision's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Catheter Precision's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 412 K | 259.3 K | |
| Pretax Profit Margin | (159.67) | (167.65) | |
| Operating Profit Margin | (176.74) | (185.58) | |
| Net Loss | (159.67) | (167.65) | |
| Gross Profit Margin | 0.93 | 0.98 |
Catheter Precision Growth Indicators
Investing in growth stocks can be very risky. If the company such as Catheter Precision does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 5.5 M |
Catheter Precision Current Valuation Indicators
Catheter Precision's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Catheter Precision's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Catheter Precision, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Catheter Precision's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Catheter Precision's worth.When determining whether Catheter Precision is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Catheter Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Catheter Precision Stock. Highlighted below are key reports to facilitate an investment decision about Catheter Precision Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 30.61 | Revenue Per Share 0.604 | Quarterly Revenue Growth (0.03) | Return On Assets (0.22) | Return On Equity (0.50) |
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.